A2M | Alpha-2-macroglobulin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
A2ML1 | Alpha-2-macroglobulin-like 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
A4GNT | Alpha-1,4-N-acetylglucosaminyltransferase | Predicted secreted proteins
| | | | | Tissue enriched |
AASS | Aminoadipate-semialdehyde synthase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ABAT | 4-aminobutyrate aminotransferase | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ABCA7 | ATP-binding cassette, sub-family A (ABC1), member 7 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ABCC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 11 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCC3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | Cancer-related genes Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
ABCC4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCD3 | ATP-binding cassette, sub-family D (ALD), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ACAD9 | Acyl-CoA dehydrogenase family, member 9 | Disease related genes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
ACADVL | Acyl-CoA dehydrogenase, very long chain | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ACBD5 | Acyl-CoA binding domain containing 5 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ACKR1 | Atypical chemokine receptor 1 (Duffy blood group) | Blood group antigen proteins CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
ACKR2 | Atypical chemokine receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
ACLY | ATP citrate lyase | Cancer-related genes Citric acid cycle related proteins Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ACOX1 | Acyl-CoA oxidase 1, palmitoyl | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ACP5 | Acid phosphatase 5, tartrate resistant | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ACPP | Acid phosphatase, prostate | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACR | Acrosin | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
ACRBP | Acrosin binding protein | Predicted secreted proteins
| | | | | Tissue enriched |
ACSBG2 | Acyl-CoA synthetase bubblegum family member 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ACSF3 | Acyl-CoA synthetase family member 3 | Disease related genes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSL4 | Acyl-CoA synthetase long-chain family member 4 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSL5 | Acyl-CoA synthetase long-chain family member 5 | Enzymes Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSM2A | Acyl-CoA synthetase medium-chain family member 2A | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ACSM2B | Acyl-CoA synthetase medium-chain family member 2B | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ACSS1 | Acyl-CoA synthetase short-chain family member 1 | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ACTN2 | Actinin, alpha 2 | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
ACTN4 | Actinin, alpha 4 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ADAM12 | ADAM metallopeptidase domain 12 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM17 | ADAM metallopeptidase domain 17 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM2 | ADAM metallopeptidase domain 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM20 | ADAM metallopeptidase domain 20 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM7 | ADAM metallopeptidase domain 7 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Not detected |
ADAMTS6 | ADAM metallopeptidase with thrombospondin type 1 motif, 6 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Mixed |
ADCK4 | AarF domain containing kinase 4 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ADCK5 | AarF domain containing kinase 5 | Enzymes Predicted membrane proteins
| | | | | Mixed |
ADCY2 | Adenylate cyclase 2 (brain) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADCY8 | Adenylate cyclase 8 (brain) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ADPRHL1 | ADP-ribosylhydrolase like 1 | Predicted intracellular proteins
| | | | | Group enriched |
ADRB1 | Adrenoceptor beta 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADSL | Adenylosuccinate lyase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
AFG3L2 | AFG3-like AAA ATPase 2 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGK | Acylglycerol kinase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |